Can Multi-Peril Insurance Policies Mitigate Adverse Selection?
Risks · 20.06.2024 · 12 (6) · 102
DOI: 10.3390/risks12060102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Risks, online erschienen am 20.06.2024. Verfasst von Peter Zweifel und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of this paper is to pursue an intuitive idea: for a consumer who represents an “unfavorable” health risk but an “excellent risk” as a driver, a multi-peril policy could be associated with a reduced selection effort on the part of the insurer. If this intuition should be confirmed, it will serve to address the decade-long concern with risk selection both in the economic literature and on the part of policy makers. As an illustrative example, a two-peril model is developed in which consumers deploy effort in search of a policy offering them maximum coverage at the current market price while insurers deploy effort designed to stave off unfavorable risks. Two types of Nash equilibria are compared: one in which the insurer is confronted with high-risk and low-risk types, and another one where both types are a “better risk” with regard to a second peril. The difference in the insurer’s selection effort directed at high-risk and low-risk types is indeed shown to be lower in the latter case, resulting in a mitigation of adverse selection.
Zitieren
APA
Zweifel, P., & Hofmann, A. (2024). Can Multi-Peril Insurance Policies Mitigate Adverse Selection?. Risks, 12(6), 102. https://doi.org/10.3390/risks12060102
Vancouver
Zweifel P, Hofmann A. Can Multi-Peril Insurance Policies Mitigate Adverse Selection?. Risks. 2024;12(6):102. doi:10.3390/risks12060102
BibTeX
@article{Zweifel2024,
author = {Zweifel, Peter and Hofmann, Annette},
title = {Can Multi-Peril Insurance Policies Mitigate Adverse Selection?},
journal = {Risks},
year = {2024},
volume = {12},
number = {6},
pages = {102},
doi = {10.3390/risks12060102}
}
EUVIMED